Get started
Author

Amit K. Tiwari

Observed name: Amit K Tiwari
ORCID: 0000-0002-0275-0724
Observed ORCIDs: 0000-0002-0275-0724, 0000-0002-7427-7155
OpenAlex ID: A5072002603
Microbial Metabolites-induced Epigenetic Modifications for Inhibition of Colorectal Cancer: Current Status and Future Perspectives
2024 · Vaibhav Singh, Ekta Shirbhate, et al. · Mini-Reviews in Medicinal Chemistry · 21
The use of zebrafish model in prostate cancer therapeutic development and discovery
2021 · Haneen Amawi, Alaa A. A. Aljabali, et al. · Cancer Chemotherapy and Pharmacology · 12
The hidden hand of endoplasmic reticulum stress in anticancer drug resistance
2025 · Joyeeta T. Khan, Saloni Sood, et al. · Critical Reviews in Oncology/Hematology · 8
Dietary Plant Metabolites Induced Epigenetic Modification as a Novel Strategy for the Management of Prostate Cancer
2024 · Vaibhav Singh, Ekta Shirbhate, et al. · Mini-Reviews in Medicinal Chemistry · 6
Strategies to Combat Resistance to Anti-angiogenesis Therapies in Cancer: Current Status and Future Prospects
2025 · Vijay K Patel, Ekta Shirbhate, et al. · Current Topics in Medicinal Chemistry · 5
Targeting Lysosomes: A Strategy Against Chemoresistance in Cancer
2024 · Ekta Shirbhate, Vaibhav Singh, et al. · Mini-Reviews in Medicinal Chemistry · 5
3D-Printed Capsaicin-Loaded Injectable Implants for Targeted Delivery in Obese Patients
2023 · Manjusha Annaji, Nur Mita, et al. · AAPS PharmSciTech · 5
The Role of Cytokines in Activation of Tumour-promoting Pathways and Emergence of Cancer Drug Resistance
2024 · Ekta Shirbhate, Vaibhav Singh, et al. · Current Topics in Medicinal Chemistry · 4
Revisiting strategies to target ABC transporter-mediated drug resistance in CNS cancer
2025 · Haneen Amawi, Alaa M. Hammad, et al. · Cancer Biology and Medicine · 3
PDF
HDAC Inhibitors in Hematological and Solid Tumor Therapy: Current Success, Challenges, and Future Directions
2026 · Vaibhav Singh, Shadiya Parveen, et al. · Current Topics in Medicinal Chemistry · 2
Epigenetic–Genetic Crosstalk at the Cancer–Diabetes Interface: Convergent Molecular Pathways, Multi‐Omics Biomarkers, and Dual Therapeutic Targets
2026 · Vaibhav Singh, Ekta Shirbhate, et al. · The FASEB Journal · 1
Mitochondrial Dynamics and Bioenergetic Reprogramming: Drivers of Cancer Therapy Resistance
2026 · Varsha Johariya, Vaibhav Singh, et al. · Mini-Reviews in Medicinal Chemistry
Vacuolization as a Novel Approach to Cancer Therapy
2026 · Mariah Pasternak, Noor Hussein, et al. · Journal of Biochemical and Molecular Toxicology
Abstract LB315: Targeting endolysosomal trafficking to overcome paclitaxel resistance in triple-negative breast cancer
2026 · Rajiv Pathak, Prabhash Nath Tripathi, et al. · Cancer Research
Stability of Ketamine-Xylazine-Butorphanol formulation to establish an evidence-based beyond-use date
2026 · Susan M. Elrod, Ishwor Poudel, et al. · Current Pharmaceutical Analysis
Apolipoprotein E and precision medicine: Individualized disease management approaches
2026 · Vaibhav Singh, Ekta Shirbhate, et al. · Elsevier eBooks
Contributors
2026 · Saheem Ahmad, Qadir Alam, et al. · Elsevier eBooks
Polyphenols in Cancer Prevention: Mechanisms of Action Against Carcinogenesis and Epidemiological Evidence of Risk Reduction
2026 · Vivek P. Chavda, Joyeeta T. Khan, et al. · Springer eBooks
Ciramadol
2026 · Rajiv Pathak, Ganesh P Mishra, et al. · Elsevier eBooks
Tolmetin
2026 · Chirag Patel, Sai H.S. Boddu, et al. · Elsevier eBooks
Targeting Microbiome-Derived Exosomes to Overcome Cancer Therapy Resistance: Mechanisms, Implications, and Opportunities
2025 · Vaibhav Singh, Ekta Shirbhate, et al. · Mini-Reviews in Medicinal Chemistry
Contributors
2025 · Mazen Al-Mohaya, Moawia M. Al-Tabakha, et al. · Elsevier eBooks
List of contributors
2022 · Manjusha Annaji, Robert D. Arnold, et al. · Elsevier eBooks
Transformative Approaches to Improve Chemotherapy for Difficult to Treat Solid Tumors
2021 · Amit K. Tiwari · Current Pharmaceutical Design
Works count: 24
Citation count: 72
H-index: 5
I10-index: 2
Year
Topic
Type